Company
Overview
Core Values
Executive Leadership
Services
Discovery & Preclinical
Pharmacology Services
Drug Safety Assessment
General Toxicology
Safety Pharmacology
Genetic Toxicology
Early Clinical Research (Phase 0 – IIa)
Phase 0-IIa
Bioequivalence Studies
Pharmacokinetics / Pharmacodynamics
Bioanalytical Services
Small Molecule Bioanalysis
Large Molecule Bioanalysis
Validated Assays
Global Central Lab
Global Services
Centralized Cardiac Services
ECG Devices
ECG Locations
Quality Assurance
Development & Regulatory Services
Drug Development
Biopharmaceutical Development
Regulatory Affairs
Program Management
Quality Assurance Services
Cardiac Safety Center of Excellence
List A-Z
List by Location
Locations
All Locations
Executive Offices
Discovery & Preclinical
Early Clinical Research
Bioanalytical Services
Global Central Lab
Scientific Library
Case Studies
Podcasts
Posters
Webinars
White Papers
Events
News
News Releases
Media Coverage
Contact Us
Study Participation
Medical Investigators
Careers at MDS
MDS Pharma Services News
June 23, 2009
MDS Pharma Services Begins 3,500th Study With ClinQuick® Electronic Data Acquisition System
June 16, 2009
MDS Pharma Services Bioanalysis Experts to Discuss Characterization of Biosimilars at AAPS National Biotechnology Conference
Upcoming Events
ASBMR 31st Annual Meeting, Denver, CO,
September 11-15, 2009
Home
/
Services
/
Early Clinical Research
/
PK/PD
/
Statistical Analysis
Statistical Analysis
MDS Pharma Services provides full statistical support for your clinical study. The statistical staff provides input throughout the clinical trial including protocol development, database lock procedures, statistical analysis of safety, efficacy and pharmacokinetic data, production of tables, figures and listings, and data interpretation in the report. The expertise of our statistical staff includes:
Knowledge of current FDA opinions and methods for statistical analysis
Experience with statistical analysis of QT/QTc, PK, PD and Biomarker endpoints
Generation of randomization schedules
Writing of integrated statistical analysis plan
Selection of appropriate statistical methods
Defining analysis populations
Creation and documentation of logical edit checks
Conducting blinded reviews of data and interim analysis
Identifying outliers
Writing and documenting validated SAS programs for data analysis and reporting
Early Clinical Research
Phase I-IIa
Bioequivalence Studies
PK/PD
Study Design and Protocol Development
Data Management
Statistical Analysis
PK/PD Analysis
Medical Writing and Reporting
Modeling and Simulation
Consultation
© 2009 MDS Pharma Services |
Corporate Governance
|
Legal
|
Privacy
|
Site Map